Patents/Assignees

PANDION OPERATIONS, Inc.

5 patents in portfolio

USRE050550reissue2025
IL-2 Muteins and Uses Thereof
0 cites
US11981715utility2024
Tissue Targeted Immunotolerance with a CD39 Effector
0 cites
US11965008utility2024
IL-2 Muteins and Uses Thereof
0 cites
US11945852utility2024
IL-2 Muteins and Uses Thereof
0 cites
US11739146utility2023
Madcam Targeted Immunotolerance
0 cites